id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0319-0003,FDA,FDA-2002-N-0319,Antimicrobial Drug Development: Public Workshop  (11/20/2002) - Transcript,Other,TR-Transcript,2009-03-08T04:00:00Z,2009,3,2009-03-08T04:00:00Z,,2009-03-08T15:06:00Z,,0,0,09000064804a00df
FDA-2002-N-0319-0002,FDA,FDA-2002-N-0319,Antimicrobial Drug Development: Public Workshop (11/19/2002) - Transcript,Other,TR-Transcript,2009-03-08T04:00:00Z,2009,3,2009-03-08T04:00:00Z,,2009-03-08T15:05:17Z,,0,0,09000064804a00c2